北美脱发治疗市场 – 行业趋势和 2030 年预测

北美脱发治疗市场分析及规模         

脱发症是指因特定疾病或营养失调引起的脱发。久坐的生活方式和不健康的饮食习惯导致脱发越来越普遍。此外，脱发还因衰老和荷尔蒙失衡以及关节炎、癌症、高血压和抑郁症等慢性疾病的增加而引起，尤其是在中年人群中。根据美国脱发协会的数据，雄激素性脱发占男性脱发的近 95%。全球有超过 80 万人正在寻找解决脱发的方法。

Data Bridge Market Research 分析，脱发治疗市场规模在 2022 年为 19.4787 亿美元，到 2030 年将达到 30.8126 亿美元，预计在预测期内的复合年增长率为 5.90%。由于“米诺地尔”在治疗脱发方面具有优势，它在脱发治疗市场药物类型细分市场中占据最大市场份额。除了对市场价值、增长率、细分市场、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Alopecia is an autoimmune skin condition that affects the growth of healthy hair follicles on the scalp, face, and other parts of the body. The type of alopecia areata, the patient's age, and the extent of hair loss all influence treatment. Alopecia treatment focuses on inhibiting the immune system from attacking the hair and encouraging it to regrow. Finasteride, minoxidil and cyclosporine are the alopecia treatment (hair loss) drugs which are indicated for alopecia treatment. Phototherapy, also known as low light laser therapy (LLLT), is gaining popularity around the world since it is less invasive and safer than other therapies.

North America Alopecia Treatment (Hair Loss) Market Dynamics

Drivers

• Increasing prevalence of hair loss

The rising prevalence of hair loss is estimated to enhance the growth of the alopecia treatment (hair loss) market. In 2018, the American Academy of Dermatology Association (AAD) projected that about 50 million men and 30 million women in the United States were plagued with alopecia. According to the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the population suffers from hair thinning, with pattern hair loss being the most common kind of hair loss in both men and women. Furthermore, roughly 2% of the entire population, regardless of gender, is at risk of acquiring alopecia treatment (hair loss) in their lifetime.

• Advancements in treatment technologies

Advancements in alopecia treatment technologies, such as the development of novel medications, surgical procedures like hair transplantation, and innovative therapies like platelet-rich plasma (PRP) treatments, are key drivers of market growth. These advancements offer patients a diverse range of effective and tailored solutions, contributing to increased demand for alopecia treatments. As the field continues to evolve, patients are likely to benefit from a growing array of options that are both technologically advanced and less invasive, thereby fueling the expansion of the alopecia treatment market in North America.

Opportunities

• Innovation in treatment modalities

The growth of the alopecia treatment market spurs innovation in pharmaceuticals, surgery, and therapies. Research and development efforts focus on creating advanced medications, surgical techniques, and therapies such as regenerative medicine to provide patients with more effective and tailored solutions, driving continuous evolution in the field.

• Rise in cosmetic procedures and clinics

The expanding alopecia treatment market offers a growth opportunity for cosmetic clinics. Entrepreneurs can establish specialized clinics offering a range of services, including advanced surgical interventions and non-surgical treatments. This trend not only caters to the rising demand for aesthetic solutions but also creates a niche for clinics dedicated to addressing hair-related concerns.

Restraints/Challenges

• High treatment costs

The high costs associated with certain alopecia treatments, such as hair transplantation or cutting-edge therapies, pose a significant barrier to accessibility. Affordability concerns may limit the adoption of these treatments, prompting a need for cost-effective alternatives and strategies to improve financial access for a broader patient demographic.

• Adverse side effects

Potential side effects associated with alopecia treatments can deter patients from pursuing interventions. Balancing the benefits and risks becomes crucial, and addressing concerns related to adverse effects requires transparent communication between healthcare providers and patients. Minimizing side effects through ongoing research and development is essential for enhancing the safety profile of alopecia treatments.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the alopecia treatment (hair loss) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• 2021 年 8 月，辉瑞公司宣布了利替尼在脱发治疗中的 2b/3 期试验的积极顶线结果。利替尼是一类新型共价激酶抑制剂中的第一个，该抑制剂以极高的选择性靶向 Janus 激酶 3 (JAK3) 和肝细胞癌 (TEC) 激酶家族中表达的酪氨酸激酶成员。实验室实验发现，利替尼可以阻止信号分子和免疫细胞的功能，而这些分子和免疫细胞被认为会导致脱发治疗患者脱发

北美脱发治疗（脱发）市场范围

脱发治疗市场根据药物类型、适应症、诊断、性别、给药途径、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

药物类型

• 米诺地尔
• 非那雄胺
• 其他的

指征

• 雄激素性脱发
• 斑秃
• 全秃
• 其他的

诊断

• 毛发镜检查
• 皮肤活检
• 其他的

性别

• 男性
• 女性

给药途径

• 口服
• 主题
• 肠外
• 其他的

最终用户

• 医院
• 专科诊所
• 家庭护理
• 其他的

分销渠道

• 医院药房
• 零售药店
• 网上药店
• 其他的

北美脱发治疗（脱发）市场区域分析/见解

对脱发治疗（脱发）市场进行了分析，并按国家、药物类型、适应症、诊断、性别、给药途径、最终用户和分销渠道提供了市场规模洞察和趋势。

脱发治疗市场报告涉及的国家包括美国、加拿大和墨西哥。

由于男性脱发患病率的不断上升以及治疗美容手术的进步，预计美国将在预测期内以最高的市场份额和增长率主导脱发治疗（脱发）市场。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

脱发治疗市场还为您提供每个国家/地区资本设备医疗支出增长、脱发治疗市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对脱发治疗市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和北美脱发治疗（脱发）市场份额分析

脱发治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对脱发治疗市场的关注有关。

脱发治疗市场的一些主要参与者包括：

• 强生私人有限公司（美国）
• 葛兰素史克公司 (英国)
• 默克公司（美国）
• 辉瑞公司（美国）
• 太阳制药工业有限公司 (印度)
• Teva Pharmaceutical Industries Ltd.（爱尔兰）
• Cipla Inc.（美国）
• Endo International plc（爱尔兰）
• Zydus Cadila（印度）
• 雅培（美国）
• Aurobindo Pharma（印度）
• Dr. Reddy's Laboratories Ltd.（印度）
• Perrigo Company plc（爱尔兰）
• Curallux, LLC.（美国）
• DR. KURT WOLFF GMBH & CO. KG（德国）
• WOCKHARDT（印度）

SKU-57065